Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole sodium (R-isomer) extended‑release capsules vs placebo in symptomatic non‑erosive GERD
CTR20160799Phase 3Completed
- Sponsor
- Takeda
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Started Nov 2016; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on CTR20160799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160799.